Global initiative to eliminate cervical cancer: HPV vaccination and screening
Cervical cancer, a major cause of morbidity and mortality, especially in low and lower-middle-income countries, is preventable. Professor Harald zur Hausen's 2008 Nobel Prize-winning discovery of HPV as the cause led to vaccines and detection tests. The WHO launched an initiative in 2018, with a global strategy in 2020, to eliminate cervical cancer by 2030, targeting 90% HPV vaccination for girls under 15, 70% screening for women at 35 and 45, and 90% treatment. India's National HPV Vaccination Campaign, launched on February 28, 2026, signifies high political commitment, offering free vaccination to 14-year-old daughters.
Key Points
- Cervical cancer is a preventable disease, primarily caused by persistent Human Papillomavirus (HPV) infection.
- The WHO's 2018 initiative aims to eliminate cervical cancer by 2030 through specific targets for HPV vaccination, screening, and treatment.
- HPV vaccines are highly effective, providing 85-90% protection against cancers caused by virulent strains like HPV 16 and 18.
- India has launched its National HPV Vaccination Campaign on February 28, 2026, offering free vaccination to 14-year-old girls.
- Early detection through pap smear screening and treatment of precancerous stages (Cervical Intraepithelial Neoplasia - CIN) are crucial for prevention.
Exam Facts
- Professor Harald zur Hausen received Nobel Prize: 2008 (for HPV discovery).
- WHO cervical cancer elimination initiative launched: 2018.
- Global strategy formally launched: November 17, 2020.
- India's National HPV Vaccination Campaign launched: February 28, 2026.
- Target for cervical cancer elimination: incidence rate of four per 1,00,000 by 2030.
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.